ES2392489T3 - Dicarbazoles y procedimientos de uso - Google Patents

Dicarbazoles y procedimientos de uso Download PDF

Info

Publication number
ES2392489T3
ES2392489T3 ES09762885T ES09762885T ES2392489T3 ES 2392489 T3 ES2392489 T3 ES 2392489T3 ES 09762885 T ES09762885 T ES 09762885T ES 09762885 T ES09762885 T ES 09762885T ES 2392489 T3 ES2392489 T3 ES 2392489T3
Authority
ES
Spain
Prior art keywords
alkyl
cr14r15
groups
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09762885T
Other languages
English (en)
Spanish (es)
Inventor
Hazel Joan Dyke
Emanuela Gancia
Lewis J. Gazzard
Simon Charles Goodacre
Joseph P. Lyssikatos
Calum Macleod
Karen Williams
Huifen Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2392489T3 publication Critical patent/ES2392489T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES09762885T 2008-06-11 2009-06-10 Dicarbazoles y procedimientos de uso Active ES2392489T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6075008P 2008-06-11 2008-06-11
US60750P 2008-06-11
US14800409P 2009-01-28 2009-01-28
US148004P 2009-01-28
PCT/US2009/003481 WO2009151589A1 (en) 2008-06-11 2009-06-10 Diazacarbazoles and methods of use

Publications (1)

Publication Number Publication Date
ES2392489T3 true ES2392489T3 (es) 2012-12-11

Family

ID=41066268

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09762885T Active ES2392489T3 (es) 2008-06-11 2009-06-10 Dicarbazoles y procedimientos de uso

Country Status (12)

Country Link
US (1) US20110124654A1 (https=)
EP (1) EP2324024B1 (https=)
JP (2) JP5677945B2 (https=)
KR (2) KR20110015699A (https=)
CN (1) CN102119162B (https=)
AU (1) AU2009258115B2 (https=)
BR (1) BRPI0909957A2 (https=)
CA (1) CA2726114A1 (https=)
ES (1) ES2392489T3 (https=)
IL (1) IL209548A (https=)
MX (1) MX2010013606A (https=)
WO (1) WO2009151589A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20110015699A (ko) * 2008-06-11 2011-02-16 제넨테크, 인크. 디아자카르바졸 및 사용 방법
RU2017127088A (ru) 2010-11-16 2019-02-04 Эррэй Биофарма Инк. Комбинация ингибиторов чекпойнт-киназы 1 и ингибиторов киназы wee 1
GB201201566D0 (en) * 2012-01-30 2012-03-14 Vernalis R&D Ltd New chemical compounds
SG11201406818VA (en) * 2012-04-23 2014-11-27 Genentech Inc Intermediates and processes for preparing compounds
WO2014116859A1 (en) * 2013-01-23 2014-07-31 The University Of Chicago Methods and compositions for inhibiting human copper trafficking proteins atox1 and ccs
CN112472699A (zh) 2013-07-26 2021-03-12 种族肿瘤学公司 改善比生群及衍生物的治疗益处的组合方法
CN105358558B (zh) 2013-10-08 2017-09-26 豪夫迈·罗氏有限公司 作为tau‑pet‑配体的二氮杂咔唑衍生物
JP6840931B2 (ja) * 2015-03-09 2021-03-10 東ソー株式会社 縮環芳香族化合物の製造方法
US20170067946A1 (en) 2015-06-08 2017-03-09 Zac WHEELER Monitoring system with low power usage
RU2019102647A (ru) 2016-07-01 2020-08-03 Г1 Терапьютикс, Инк. Антипролиферационные средства на основе пиримидина
MX375720B (es) 2016-09-09 2025-03-04 Hoffmann La Roche Proceso para preparacion de 2-(6-nitropiridin-3-il)-9h-dipirido[2,3-beta;3',4'-d]pirrol.
WO2019168874A1 (en) 2018-02-27 2019-09-06 The Research Foundation For The State University Of New York Difluoromethoxylation and trifluoromethoxylation compositions and methods for synthesizing same
KR20230012547A (ko) 2020-05-19 2023-01-26 쥐원 쎄라퓨틱스, 인크. 의학적 장애의 치료를 위한 시클린-의존성 키나제 억제 화합물
CN115572282B (zh) * 2021-07-05 2024-07-09 华东理工大学 含芳杂环结构的吡唑酰胺类化合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1054039B (zh) * 2000-03-15 2010-04-16 萨诺费－阿文蒂斯德国有限公司 取代的β-咔啉
EP1268477B1 (en) 2000-03-15 2010-04-21 Sanofi-Aventis Deutschland GmbH Substituted beta-carbolines with ikb-kinase inhibiting activity
KR100774855B1 (ko) * 2000-04-27 2007-11-08 아스텔라스세이야쿠 가부시키가이샤 축합 헤테로아릴 유도체
US6608053B2 (en) * 2000-04-27 2003-08-19 Yamanouchi Pharmaceutical Co., Ltd. Fused heteroaryl derivatives
EP1599202A1 (en) * 2003-02-17 2005-11-30 Pharmacia Italia S.p.A. Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
PE20060526A1 (es) * 2004-06-15 2006-07-13 Schering Corp Compuestos triciclicos como antagonistas de mglur1
US8119655B2 (en) * 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
US8618121B2 (en) 2007-07-02 2013-12-31 Cancer Research Technology Limited 9H-pyrimido[4,5-B]indoles, 9H-pyrido[4',3':4,5]pyrrolo[2,3-D]pyridines, and 9H 1,3,6,9 tetraaza-fluorenes as CHK1 kinase function inhibitors
KR20110015699A (ko) * 2008-06-11 2011-02-16 제넨테크, 인크. 디아자카르바졸 및 사용 방법

Also Published As

Publication number Publication date
EP2324024B1 (en) 2012-09-26
CA2726114A1 (en) 2009-12-17
KR101764556B1 (ko) 2017-08-02
IL209548A (en) 2014-03-31
WO2009151589A1 (en) 2009-12-17
JP2011522888A (ja) 2011-08-04
AU2009258115B2 (en) 2015-01-29
IL209548A0 (en) 2011-01-31
BRPI0909957A2 (pt) 2016-04-19
AU2009258115A1 (en) 2009-12-17
KR20160074680A (ko) 2016-06-28
AU2009258115A2 (en) 2011-05-12
MX2010013606A (es) 2010-12-21
JP5677945B2 (ja) 2015-02-25
EP2324024A1 (en) 2011-05-25
JP2014196309A (ja) 2014-10-16
US20110124654A1 (en) 2011-05-26
CN102119162A (zh) 2011-07-06
CN102119162B (zh) 2014-10-08
KR20110015699A (ko) 2011-02-16

Similar Documents

Publication Publication Date Title
ES2392489T3 (es) Dicarbazoles y procedimientos de uso
ES2399774T3 (es) Compuestos de tiazolopirimidina inhibidores de PI3K y métodos de uso
AU2009258124C1 (en) Diazacarbazoles and methods of use
ES2392488T3 (es) Compuestos inhibidores de PI3K de tipo pirazolopiridina y sus procedimientos de uso
EP2164850B1 (en) N-substituted azaindoles and methods of use
CA2698753A1 (en) Pyrazolo-pyridines as tyrosine kinase inhibitors
CA2782213A1 (en) 1,7-diazacarbazoles and their use in the treatment of cancer
BR112012011147A2 (pt) Composto, composição farmacêutica e uso de um composto.
JP2015504876A (ja) セリン／トレオニンキナーゼ阻害剤としての２，４−ジアミン−ピリミジン誘導体
AU2014331049B2 (en) Conformationally restricted PI3K and mTOR inhibitors
EP2300457B1 (en) Substituted pyrroles and methods of use
US20150368244A1 (en) Diazacarbazoles and methods of use
WO2023116594A1 (zh) 取代的稠杂环化合物及其制备方法与应用
HK40091719A (zh) 取代的稠杂环化合物及其制备方法与应用
HK40091719B (zh) 取代的稠杂环化合物及其制备方法与应用